Issue of Shares

Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces that it is has agreed full and final settlement with former corporate advisors regarding outstanding fees relating to past corporate advisory and capital-raising services.

Wellnex Life will issue a total of 3,071,336 fully paid ordinary shares (New Shares) at a reference price (deemed issue price) of A$0.074 per New Share being the ASX closing price on 26 March 2026. The New Shares will be issued under the Company's existing Listing Rule 7.1 placement capacity.

AIM Application and Total Voting Rights

Application has been made for the admission of the New Shares to trading on AIM. It is expected that, admission will become effective and dealings in the New Shares will commence on AIM at 8.00 a.m. (UK time) on or around 2 April 2026. An Appendix 3B will be lodged with the ASX separately in relation to the issue of Shares.

The New Shares are being issued fully paid and ranking pari passu in all respects with the Company's existing ordinary shares.

Following Admission, the Company's issued share capital will comprise of 73,026,812 ordinary shares, none of which are held in treasury. Accordingly, the figure of 73,026,812 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules and the provisions of the Company's constitution.

This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).